Janet Xiao

Patent Strategy + Prosecution; IP Due Diligence; Venture Intellectual Property; Patent Litigation

Janet specializes in world-wide patent procurement, patent portfolio management, and strategic planning for life sciences companies. She is among a few IP attorneys in the world who are both equipped with skills in global strategic IP management and knowledgeable about IP issues unique to China and Chinese clients.

Her clients range from large multinational biopharmaceutical companies to emerging startup companies around the world. She advises on patent matters relating to various technologies, including antibody and cell therapeutics, nanomedicine, gene therapy, drug delivery systems, diagnostics, and nutraceuticals. With every engagement, Janet is focused on driving value and leveraging her creative legal skills, business acumen, and solid foundation in science to advise clients on critical IP issues. Janet works extensively in performing IP due diligence reviews in VC investments, technology transactions, M&A, and marketing and manufacturing clearance for biopharmaceutical products. She has led hundreds of IP due diligence projects, and has in-depth knowledge of patent landscapes in the fields of cancer immunotherapy, gene editing, next-generation sequencing, liquid biopsy, antibody manufacturing, and medical devices.

J.D., University of California, Berkeley, School of Law; Ph.D., University of California, Los Angeles; M.S., Chinese Academy